BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33425384)

  • 1. Area under the Curve-Based Dosing of Vancomycin in Critically Ill Patients Using 6-Hour Urine Creatinine Clearance Measurement.
    Shahrami B; Najmeddin F; Ghaffari S; Najafi A; Rouini MR; Mojtahedzadeh M
    Crit Care Res Pract; 2020; 2020():8831138. PubMed ID: 33425384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of safe and effective dose of vancomycin in MRSA-infected patients using serum cystatin C concentrations.
    Chen YC; Feng JF; Li B; Zhang L; Yang YW
    Int J Clin Pharmacol Ther; 2013 Mar; 51(3):161-9. PubMed ID: 23195915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized Delivery of Vancomycin by Model-Informed Bayesian Dosing Approach to Maintain an AUC24 Target in Critically Ill Patients.
    Rao Z; Guo SM; Wei YM
    Chemotherapy; 2024; 69(1):49-55. PubMed ID: 37591210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular filtration rate correlation and agreement between common predictive equations and standard 24-hour urinary creatinine clearance in medical critically ill patients.
    Wongpraphairot S; Thongrueang A; Bhurayanontachai R
    PeerJ; 2022; 10():e13556. PubMed ID: 35669965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between vancomycin clearance and cystatin C-based glomerular filtration rate in paediatric patients.
    Oh Y; Park S; Park E; Lee J; Lee H; Kim J; Cho J
    Br J Clin Pharmacol; 2021 Aug; 87(8):3190-3196. PubMed ID: 33496976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive performance of population pharmacokinetic software on vancomycin steady-state trough concentration].
    Xue S; Lu H; Tang L; Fang J; Shi L; Li J; Yu Y; Zhou Q; Xue S
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):50-55. PubMed ID: 32148231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented Renal Clearance Using Population-Based Pharmacokinetic Modeling in Critically Ill Pediatric Patients.
    Avedissian SN; Bradley E; Zhang D; Bradley JS; Nazer LH; Tran TM; Nguyen A; Le J
    Pediatr Crit Care Med; 2017 Sep; 18(9):e388-e394. PubMed ID: 28640009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Larger Dose of Vancomycin Is Required in Adult Neurosurgical Intensive Care Unit Patients Due to Augmented Clearance.
    Lin Wu FL; Liu SS; Yang TY; Win MF; Lin SW; Huang CF; Wang KC; Shen LJ
    Ther Drug Monit; 2015 Oct; 37(5):609-18. PubMed ID: 25627406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
    Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
    Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing.
    Donahue A; McCune JS; Faucette S; Gillenwater HH; Kowalski RJ; Socinski MA; Lindley C
    Cancer Chemother Pharmacol; 2001 May; 47(5):373-9. PubMed ID: 11391850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population Pharmacokinetics and Dose Optimization of Vancomycin in Critically Ill Children.
    Sridharan K; Abbasi MY; Mulubwa M
    Eur J Drug Metab Pharmacokinet; 2021 Jul; 46(4):539-546. PubMed ID: 34156647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictability of creatinine clearance estimates in critically ill patients.
    Robert S; Zarowitz BJ; Peterson EL; Dumler F
    Crit Care Med; 1993 Oct; 21(10):1487-95. PubMed ID: 8403957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective Comparison of Estimated GFR using 2006 MDRD, 2009 CKD-EPI and Cockcroft-Gault with 24 Hour Urine Creatinine Clearance.
    Kumar BV; Mohan T
    J Clin Diagn Res; 2017 May; 11(5):BC09-BC12. PubMed ID: 28658750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing Vancomycin Therapy in Critically Ill Children: A Population Pharmacokinetics Study to Inform Vancomycin Area under the Curve Estimation Using Novel Biomarkers.
    Downes KJ; Zuppa AF; Sharova A; Neely MN
    Pharmaceutics; 2023 Apr; 15(5):. PubMed ID: 37242578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetics and Dosing Simulation of Vancomycin Administered by Continuous Injection in Critically Ill Patient.
    Garreau R; Falquet B; Mioux L; Bourguignon L; Ferry T; Tod M; Wallet F; Friggeri A; Richard JC; Goutelle S
    Antibiotics (Basel); 2021 Oct; 10(10):. PubMed ID: 34680809
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessing glomerular filtration rate (GFR) in critically ill patients with acute kidney injury--true GFR versus urinary creatinine clearance and estimating equations.
    Bragadottir G; Redfors B; Ricksten SE
    Crit Care; 2013 Jun; 17(3):R108. PubMed ID: 23767877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of renal clearance on vancomycin area under the concentration-time curve deviations in critically ill patients.
    Ishigo T; Ibe Y; Fujii S; Kazuma S; Aigami T; Kashiwagi Y; Takada R; Takahashi S; Fukudo M; Toda T
    J Infect Chemother; 2023 Aug; 29(8):769-777. PubMed ID: 37150254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Race-Based and Non-Race-Based Equations for Kidney Function Estimation in Critically Ill Thai Patients for Vancomycin Dosing.
    Sitaruno S; Santimaleeworagun W; Pattharachayakul S; DeBacker KC; Vattanavanit V; Binyala W; Pai MP
    J Clin Pharmacol; 2022 Oct; 62(10):1215-1226. PubMed ID: 35543614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Augmented renal clearance in critically ill patients: incidence, associated factors and effects on vancomycin treatment].
    Campassi ML; Gonzalez MC; Masevicius FD; Vazquez AR; Moseinco M; Navarro NC; Previgliano L; Rubatto NP; Benites MH; Estenssoro E; Dubin A
    Rev Bras Ter Intensiva; 2014; 26(1):13-20. PubMed ID: 24770684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
    Waineo MF; Kuhn TC; Brown DL
    J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.